You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (45) |
Back to Search
Using population pharmacokinetic modelling methods to guide individualized dosing when switching to extended half-life products in hemophilia A patients
- At: PSWC2020 (2020)
- Type: Poster
- By: YU, Jacky (UNIVERSITY OF WATERLOO, Pharmacy, Canada)
- Co-author(s): Jacky Yu: Pharmacy, University of Waterloo, Waterloo, Canada
Alfonso Iorio: Medicine, McMaster University, Hamilton, Canada
Andrea Edginton: Pharmacy, University of Waterloo, Waterloo, Canada - Abstract:
Background
Hemophilia is a bleeding disorder caused by a lack of clotting factor. Due to the development of extended half-life (EHL) clotting factor concentrates (CFC), hemophiliacs may switch their prophylactic treatment to another CFC that is dosed less frequently. When switching, CFCs are prophylactically dosed based on international units per.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026